BYSI
Price
$2.00
Change
-$0.04 (-1.96%)
Updated
Aug 8 closing price
Capitalization
80.63M
27 days until earnings call
CYTK
Price
$34.12
Change
-$1.13 (-3.21%)
Updated
Aug 8 closing price
Capitalization
4.21B
82 days until earnings call
Interact to see
Advertisement

BYSI vs CYTK

Header iconBYSI vs CYTK Comparison
Open Charts BYSI vs CYTKBanner chart's image
BeyondSpring
Price$2.00
Change-$0.04 (-1.96%)
Volume$23.01K
Capitalization80.63M
Cytokinetics
Price$34.12
Change-$1.13 (-3.21%)
Volume$2.1M
Capitalization4.21B
BYSI vs CYTK Comparison Chart in %
Loading...
BYSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BYSI vs. CYTK commentary
Aug 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BYSI is a Hold and CYTK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 09, 2025
Stock price -- (BYSI: $2.00 vs. CYTK: $34.11)
Brand notoriety: BYSI and CYTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BYSI: 28% vs. CYTK: 153%
Market capitalization -- BYSI: $80.63M vs. CYTK: $4.21B
BYSI [@Biotechnology] is valued at $80.63M. CYTK’s [@Biotechnology] market capitalization is $4.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BYSI’s FA Score shows that 0 FA rating(s) are green whileCYTK’s FA Score has 1 green FA rating(s).

  • BYSI’s FA Score: 0 green, 5 red.
  • CYTK’s FA Score: 1 green, 4 red.
According to our system of comparison, both BYSI and CYTK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BYSI’s TA Score shows that 5 TA indicator(s) are bullish while CYTK’s TA Score has 5 bullish TA indicator(s).

  • BYSI’s TA Score: 5 bullish, 5 bearish.
  • CYTK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both BYSI and CYTK are a good buy in the short-term.

Price Growth

BYSI (@Biotechnology) experienced а -3.38% price change this week, while CYTK (@Biotechnology) price change was -7.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.25%. For the same industry, the average monthly price growth was +6.85%, and the average quarterly price growth was +13.24%.

Reported Earning Dates

BYSI is expected to report earnings on Sep 05, 2025.

CYTK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+0.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($4.21B) has a higher market cap than BYSI($80.6M). BYSI YTD gains are higher at: 22.699 vs. CYTK (-27.487). BYSI has higher annual earnings (EBITDA): -9.01M vs. CYTK (-513.62M). CYTK has more cash in the bank: 938M vs. BYSI (8.53M). BYSI has less debt than CYTK: BYSI (547K) vs CYTK (791M). CYTK has higher revenues than BYSI: CYTK (19.2M) vs BYSI (0).
BYSICYTKBYSI / CYTK
Capitalization80.6M4.21B2%
EBITDA-9.01M-513.62M2%
Gain YTD22.699-27.487-83%
P/E RatioN/AN/A-
Revenue019.2M-
Total Cash8.53M938M1%
Total Debt547K791M0%
FUNDAMENTALS RATINGS
BYSI vs CYTK: Fundamental Ratings
BYSI
CYTK
OUTLOOK RATING
1..100
469
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
10091
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
4960
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BYSI's Valuation (55) in the Pharmaceuticals Major industry is somewhat better than the same rating for CYTK (100) in the Biotechnology industry. This means that BYSI’s stock grew somewhat faster than CYTK’s over the last 12 months.

CYTK's Profit vs Risk Rating (91) in the Biotechnology industry is in the same range as BYSI (100) in the Pharmaceuticals Major industry. This means that CYTK’s stock grew similarly to BYSI’s over the last 12 months.

BYSI's SMR Rating (99) in the Pharmaceuticals Major industry is in the same range as CYTK (100) in the Biotechnology industry. This means that BYSI’s stock grew similarly to CYTK’s over the last 12 months.

BYSI's Price Growth Rating (49) in the Pharmaceuticals Major industry is in the same range as CYTK (60) in the Biotechnology industry. This means that BYSI’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for BYSI (100) in the Pharmaceuticals Major industry. This means that CYTK’s stock grew significantly faster than BYSI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BYSICYTK
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
64%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 10 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 4 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
BYSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRVLX47.19N/A
N/A
T. Rowe Price Value
PHSKX59.97N/A
N/A
Virtus KAR Mid-Cap Growth A
STITX7.54N/A
N/A
Virtus SGA International Growth I
JSMTX17.99N/A
N/A
Jackson Square SMID-Cap Growth Instl
JSLNX20.30-0.03
-0.15%
Janus Henderson Global Select N

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with IMVT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
-3.23%
IMVT - CYTK
50%
Loosely correlated
-1.72%
IDYA - CYTK
48%
Loosely correlated
+3.08%
ROIV - CYTK
46%
Loosely correlated
-0.52%
BEAM - CYTK
45%
Loosely correlated
-1.34%
CRNX - CYTK
44%
Loosely correlated
-3.69%
More